Alpha-9 Oncology and NorthStar Medical Radioisotopes have entered into a supply agreement under which NorthStar will provide Alpha-9 with actinium-225.
NorthStar will be one of the first commercial-scale producers of actinium-225 for clinical research and commercial radiopharmaceutical therapy, Alpha-9 said.